Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum

Journal of Hepatology(2020)10.1016/j.jhep.2020.04.030Source: DataRank Database

Standardisation of diet and exercise in clinical trials of NAFLD-NASH: Recommendations from the Liver Forum is a research paper published in Journal of Hepatology (2020). On theSindex it has a DataRank of 0. It has been cited 88 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

88 citations

Free full text

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (111 grants)Impact (FWCI 7.95)OA: closedTopics (48)IDs (PubMed, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (0/2)

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (11)

Claudia Filozof ORCID,Mazen Noureddin ORCID,Mark Berner‐Hansen,Elmer Schabel,Stephanie O. Omokaro ORCID

Live enrichment

PubMed:32353483 OpenAlex:https://openalex.org/W3020802882

NIH

Grant: U01DK061713

Allergan

Grant: unidentified

unidentified

Allergan

Assembly Biosciences

Boehringer Ingelheim

Exalenz

HighTide Therapeutics

Mallinckrodt Pharmaceuticals

Mylan

Novartis

Somalogic

TARGET PharmaSolutions

AMRA Medical

Biogen

Bristol-Myers Squib

ConSynance

DeuteRx

Galectin Therapeutics

Gilead Sciences

Hepatitis B Foundation

Immuron

Intercept Pharmaceuticals

LabCorp

Madrigal Pharmaceuticals

MediciNova

Microbiotix

Nordic Bioscience

Northsea Therapeutics

Novo Nordisk Inc.

ProSciento

AbbVie

Abbott Molecular

Aligos Therapeutics

Arrowhead Pharmaceuticals

Astra-Zeneca

DiaPharma

Eli Lilly and Company

Enanta Pharmaceuticals, Inc.

Fractyl

Genfit

Genkyotex

Medivir

Metacrine

PPD Inc.

Resonance Health

Takeda

ViiV Healthcare

e.scopics

Aicuris

Altimmune

Celgene

Chimerix

Duke Divisions of Gastroenterology

Ferring Pharmaceuticals

Ironwood Pharmaceuticals

Morphic Therapeutic

Nimbus Therapeutics

Quest Diagnostics

SeraCare

Syneos Health

Teva Pharmaceuticals

VLVBio

3-V Biosciences

Astellas

CTI Clinical Trial and Consulting Services

Cirius Therapeutics Inc.

Conatus Pharmaceuticals, Inc.

ContraVir

EA Pharma Co., Ltd.

Genesis Imaging Services

HepQuant

ICON Clinical Research

Janssen

Merck Laboratories

Nusirt

Pliant Therapeutics

Zafgen

Arbutus Biopharma

Cirius Therapeutics

Covance

DDL Diagnostics

Durect

GlaxoSmithKline

HistoIndex Pte Ltd

Integrative Medicine

Inventiva

Perspectum Diagnostics

Shire

Springbank Pharma

Advanced Biological Laboratories

Echosens

Enyo Pharma

Genentech

Humedics GmbH

Raptor Pharmaceuticals

Resoundant

Roche Molecular Systems

Zealand Pharma

Afimmune

Cocrystal Pharma, Inc.

Cymabay

DS Biopharma

Glympse Bio

MEDIAN Technologies

Mirum

NGM Biopharmaceuticals

Nitto Denko Technical Corp

OWL Metabolomics

Pfizer

Roivant Sciences

RuiYi

FWCI

7.95

Citation Percentile

1.0%

Citation Trend

2020

2021

2022

2023

2024

2025

2026

closedLicense: Elsevier TDM

publisherhttps://api.elsevier.com/content/article/PII:S0168827820302749?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0168827820302749?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jhep.2020.04.030

repositoryhttps://pubmed.ncbi.nlm.nih.gov/32353483

https://dx.doi.org/10.1016/j.jhep.2020.04.030

Fields of Study

Liver Disease Diagnosis and TreatmentDiet, Metabolism, and DiseaseLiver Disease and Transplantation0301 basic medicine03 medical and health sciences

MeSH Terms

Diet, HealthyAdultBody WeightClinical Trials as TopicExercise TherapyHumansExerciseBody Mass IndexTreatment OutcomeWaist CircumferenceNon-alcoholic Fatty Liver Disease

Keywords

Clinical trialMedicineFatty liverContext (archaeology)SteatohepatitisDiseaseAlternative medicinePsychological interventionMEDLINEIntensive care medicinePhysical therapyInternal medicinePathologyNursingPolitical sciencefibrosisPlacebo EffectClinical StudiesEndpointsLifestyle ModificationsAdultClinical Trials as TopicBody WeightBody Mass IndexExercise TherapyTreatment OutcomeNon-alcoholic Fatty Liver DiseaseHumansHuman medicineDiet, HealthyWaist CircumferenceExercise

Sustainable Development Goals

SDG 3: 3. Good healthSDG 0: Good health and well-being